Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Molecular Biology Enzymes, Kits, and Reagents Market: By Product Type, By Application, By End Users and Geography
Molecular Biology Enzymes, Kits, and Reagents Market: By Product Type, By Application, By End Users and Geography
Molecular Biology Enzymes, Kits, and Reagents Market size was valued at US$ 15,675.9 Million in 2023 and is poised to grow at a CAGR of 17.5% over 2024-2030. Biological enzymes are important in promoting chemical reactions in biological systems. Molecular biology enzymes are recommended for the preparation of laboratory samples. These chemicals are also used in procedures like polymerase chain reaction (PCR), DNA sequencing, and cell analysis. The PCR segment is anticipated to grow at a significant CAGR over the forecast years owing to the polymerase chain reaction that includes reverse transcriptase polymerase chain reactions, one of the most used preparative and diagnostic procedures in molecular biology. Moreover, the competitive players are focusing on launching new products and acquisitions to maintain growth in the market. Through this acquisition, this segment's revenue is expected to increase by approximately US$ 200 million in 2021. Increased research and development expenditure, an increase in genome projects, technical advances in the life sciences business, and an increase in the prevalence of genetic diseases. are a few of the elements influencing the industry's growth throughout the anticipated period.
Study Period
2024– 2030Base Year
2023CAGR
17.5%Largest Market
North AmericanFastest Growing Market
Asia-Pacific
Molecular biology enzymes are utilized in a wide range of applications, including drug discovery and diagnostic testing, R&D, and life science research. Molecular biology products that are routinely used for polymerase chain reaction (PCR) analysis of cell surface markers. This includes qPCR, RT-PCR, and other preparative PCRs that have a therapeutic or diagnostic purpose. The increasing number of R&D activities in biotechnology and drug discovery is a significant growth factor for the global molecular biology enzymes, kits, and reagents market. It is expected to remain such over the projected period of 2024 to 2030.
The Molecular Biology Enzymes, Kits, and Reagents Market in North America is likely to hold the highest revenue share in 2021, and the same trend is expected over the forecast period due to the Increased frequency of hereditary and chronic diseases such as cancer, as well as positive government efforts According to the American Cancer Society, around 1,735,350 new cancer cases were identified in the United States in 2018, with roughly 609,640 fatalities. Furthermore, the region's expanding elderly population, as well as increased R&D activities, are likely to boost the market throughout the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024– 2030 |
|
Market CAGR |
17.5% |
|
By Product Type |
|
|
By Application |
|
|
By End Users |
|
|
By Region |
|
Download Free Sample Report
The molecular biology enzymes, kits, and reagents market is projected to expand at a CAGR of 17.5% during the forecast period
THERMO FISHER SCIENTIFIC INC, Illumina, Inc., Qiagen, Agilent Technologies, Inc., F. HOFFMANN-LA ROCHE LTD, Merck KGAA, Jena Bioscience GmbH, Bioline Technologies, Promega Corporation, Rockland Immunochemicals
Asia-Pacific is the fastest-growing region for molecular biology enzymes, kits, and reagents market
| 1. Executive Summary |
| 2. Global Molecular Biology Enzymes, Kits, and Reagents Market Introduction |
| 2.1. Global Molecular Biology Enzymes, Kits, and Reagents Market - Taxonomy |
| 2.2. Global Molecular Biology Enzymes, Kits, and Reagents Market -Definitions |
| 2.2.1. By Product |
| 2.2.2. By Application |
| 2.2.3. By End users |
| 2.2.4. By Region |
| 3. Global Molecular Biology Enzymes, Kits, and Reagents Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Molecular Biology Enzymes, Kits, and Reagents Market Dynamic Factors - Impact Analysis |
| 3.6. Global Molecular Biology Enzymes, Kits, and Reagents Market - Competition Landscape |
| 4. Global Molecular Biology Enzymes, Kits, and Reagents Market Analysis,2019-2023 and Forecast, 2024-2030 |
| 4.1. Market Analysis,2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Molecular Biology Enzymes, Kits, and Reagents Market, Product Type, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1. Kits & Reagents |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Enzymes |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Polymerases |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Ligases |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Restriction Endonucleases. |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Reverse Transcriptases |
| 5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Other Enzymes |
| 5.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 6. Global Molecular Biology Enzymes, Kits, and Reagents Market Forecast, By Application, 2019-2023 and Forecast, 2021 - 2027 (Revenue, USD Mn) |
| 6.1. PCR |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Sequencing |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Cloning |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Epigenetics |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Restriction Digestion |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Synthetic Biology |
| 6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Other Applications |
| 6.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7. Global Molecular Biology Enzymes, Kits, and Reagents Market, By End users, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1. Academic & Research Institutes |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Pharmaceutical & Biotechnology companies |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Hospitals & Diagnostic Centers |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Other End Users |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Molecular Biology Enzymes, Kits, and Reagents Market Forecast, By Region, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Molecular Biology Enzymes, Kits, and Reagents Market - Opportunity Analysis Index, Product Type, By Application, End User, and Region, 2024-2030 |
| 9. North America Molecular Biology Enzymes, Kits, and Reagents MarketAnalysis,2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.1. By Product Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Kits & Reagents |
| 9.1.2. Enzymes |
| 9.1.3. Polymerases |
| 9.1.4. Ligases |
| 9.1.5. Restriction Endonucleases |
| 9.1.6. Reverse Transcriptases |
| 9.1.7. Other Enzymes |
| 9.2. By Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. PCR |
| 9.2.2. Sequencing |
| 9.2.3. Cloning |
| 9.2.4. Epigenetics |
| 9.2.5. Restriction Digestion |
| 9.2.6. Synthetic Biology |
| 9.2.7. Other Applications |
| 9.3. By End users Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Academic & Research Institutes |
| 9.3.2. Pharmaceutical & Biotechnology companies |
| 9.3.3. Hospitals & Diagnostic Centers |
| 9.3.4. Other End Users |
| 9.4. Country Analysis 2019-2023 and Forecast 2024-2030by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. USA |
| 9.4.2. Canada |
| 9.5. North America Molecular Biology Enzymes, Kits, and Reagents Market - Opportunity Analysis Index, Product Type, By Application, End User, and Country, 2024-2030 |
| 9.6. North America Molecular Biology Enzymes, Kits, and Reagents Market Dynamics - Trends |
| 10. Europe Molecular Biology Enzymes, Kits, and Reagents Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 10.1. By Product Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Kits & Reagents |
| 10.1.2. Enzymes |
| 10.1.3. Polymerases |
| 10.1.4. Ligases |
| 10.1.5. Restriction Endonucleases |
| 10.1.6. Reverse Transcriptases |
| 10.1.7. Other Enzymes |
| 10.2. By Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. PCR |
| 10.2.2. Sequencing |
| 10.2.3. Cloning |
| 10.2.4. Epigenetics |
| 10.2.5. Restriction Digestion |
| 10.2.6. Synthetic Biology |
| 10.2.7. Other Applications |
| 10.3. By End users Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Academic & Research Institutes |
| 10.3.2. Pharmaceutical & Biotechnology companies |
| 10.3.3. Hospitals & Diagnostic Centers |
| 10.3.4. Other End Users |
| 10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Rest of Europe |
| 10.5. Europe Molecular Biology Enzymes, Kits, and Reagents Market - Opportunity Analysis Index, Product Type, By Application, End User, and Country, 2024-2030 |
| 10.6. Europe Molecular Biology Enzymes, Kits, and Reagents Market Dynamics - Trends |
| 11. Asia-Pacific Molecular Biology Enzymes, Kits, and Reagents Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 11.1. By Product Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Kits & Reagents |
| 11.1.2. Enzymes |
| 11.1.3. Polymerases |
| 11.1.4. Ligases |
| 11.1.5. Restriction Endonucleases |
| 11.1.6. Reverse Transcriptases |
| 11.1.7. Other Enzymes |
| 11.2. By Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. PCR |
| 11.2.2. Sequencing |
| 11.2.3. Cloning |
| 11.2.4. Epigenetics |
| 11.2.5. Restriction Digestion |
| 11.2.6. Synthetic Biology |
| 11.2.7. Other Applications |
| 11.3. By End users Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Academic & Research Institutes |
| 11.3.2. Pharmaceutical & Biotechnology companies |
| 11.3.3. Hospitals & Diagnostic Centers |
| 11.3.4. Other End Users |
| 11.4. Country Analysis2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Japan |
| 11.4.2. China |
| 11.4.3. India |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Molecular Biology Enzymes, Kits, and Reagents Market - Opportunity Analysis Index, Product Type, By Application, End User, and Country, 2024-2030 |
| 11.6. Asia-Pacific Molecular Biology Enzymes, Kits, and Reagents Market Dynamics - Trends |
| 12. Latin America Molecular Biology Enzymes, Kits, and Reagents Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 12.1. By Product Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Kits & Reagents |
| 12.1.2. Enzymes |
| 12.1.3. Polymerases |
| 12.1.4. Ligases |
| 12.1.5. Restriction Endonucleases |
| 12.1.6. Reverse Transcriptases |
| 12.1.7. Other Enzymes |
| 12.2. By Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. PCR |
| 12.2.2. Sequencing |
| 12.2.3. Cloning |
| 12.2.4. Epigenetics |
| 12.2.5. Restriction Digestion |
| 12.2.6. Synthetic Biology |
| 12.2.7. Other Applications |
| 12.3. By End users Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Academic & Research Institutes |
| 12.3.2. Pharmaceutical & Biotechnology companies |
| 12.3.3. Hospitals & Diagnostic Centers |
| 12.3.4. Other End Users |
| 12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Argentina |
| 12.4.4. Rest of Latin America |
| 12.5. Latin America Molecular Biology Enzymes, Kits, and Reagents Market - Opportunity Analysis Index, Product Type, By Application, End User, and Country, 2024-2030 |
| 12.6. Latin America Molecular Biology Enzymes, Kits, and Reagents Market Dynamics - Trends |
| 13. Middle East and Africa Molecular Biology Enzymes, Kits, and Reagents Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 13.1. By Product Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Kits & Reagents |
| 13.1.2. Enzymes |
| 13.1.3. Polymerases |
| 13.1.4. Ligases |
| 13.1.5. Restriction Endonucleases |
| 13.1.6. Reverse Transcriptases |
| 13.1.7. Other Enzymes |
| 13.2. By Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. PCR |
| 13.2.2. Sequencing |
| 13.2.3. Cloning |
| 13.2.4. Epigenetics |
| 13.2.5. Restriction Digestion |
| 13.2.6. Synthetic Biology |
| 13.2.7. Other Applications |
| 13.3. By End users Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Academic & Research Institutes |
| 13.3.2. Pharmaceutical & Biotechnology companies |
| 13.3.3. Hospitals & Diagnostic Centers |
| 13.3.4. Other End Users |
| 13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. Israel |
| 13.4.3. South Africa |
| 13.4.4. Rest of MEA |
| 13.5. MEA Molecular Biology Enzymes, Kits, and Reagents Market - Opportunity Analysis Index, Product Type, By Application, End User, and Country, 2024-2030 |
| 13.6. MEA Molecular Biology Enzymes, Kits, and Reagents Market Dynamics - Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, By Application & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. THERMO FISHER SCIENTIFIC INC |
| 14.2.2. Illumina, Inc. |
| 14.2.3. Qiagen |
| 14.2.4. Agilent Technologies, Inc. |
| 14.2.5. F. HOFFMANN-LA ROCHE LTD |
| 14.2.6. Merck KGAA |
| 14.2.7. Jena Bioscience GmbH |
| 14.2.8. Bioline Technologies |
| 14.2.9. Promega Corporation |
| 14.2.10. Rockland Immunochemicals. |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.